AI智能总结
Prospectus Supplement No. 3, dated March 3, 2025, Prospectus Supplement No. 4 dated March 10, 2025, Prospectus Supplement No.5 dated March 17, 2025, and Prospectus Supplement No. 6 dated April 7, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-283853). This Prospectus Supplement No. 7 is being filed to update, amend, and supplement the information included in the Prospectus with theinformation contained in our Current Report on Form 8-K, filed with the United States Securities and Exchange Commission on May2, 2025, which is set forth below.This Prospectus Supplement No. 7 is not complete without the Prospectus. This Prospectus Supplement No.7 should be read inconjunction with the Prospectus, which is to be delivered with this Prospectus Supplement No. 7, and is qualified by reference thereto, Our Common Stock and Warrants are traded on The Nasdaq Stock Market LLC under the symbols “DHAI.” and “DHAIW”, INVESTING IN OUR SECURITIES INVOLVES RISKS. YOU SHOULD CAREFULLY CONSIDER THE “RISKFACTORS” INCLUDED IN OUR ANNUAL REPORT ON FORM 10-K,AS AMENDED BY FORM 10-K/A,FOR THEYEAR ENDED MARCH 31, 2024 AS WELL AS SUBSEQUENTLY FILED FORM 10-QS BEFORE YOU DECIDE TO disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is acriminal offense. THE INFORMATION IN THIS PROSPECTUS SUPPLEMENT NO. 7 IS NOT COMPLETE AND MAY CHANGE. THISPROSPECTUS SUPPLEMENT NO. 7 IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITINGAN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED. SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2025 DIH HOLDING US, INC. under any of the following provisions: Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) effective upon his resignation. Mr. Ludlum’s resignation was not due to any disagreement with the Company with regard to its Item 9.01 Financial Statements and Exhibits.